HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Carlsson, P.-O. Articles by Liss, P. Search for Related Content PubMed PubMed Citation Articles by Carlsson, P.-O. Articles by Liss, P. Social Bookmarking                What's this?

Markedly Decreased Oxygen Tension in Transplanted Rat Pancreatic Islets Irrespective of the Implantation Site

¹ Departments of Medical Cell Biology
² Physiology, and
³ Diagnostic Radiology, Uppsala University, Uppsala, Sweden

In this study, we syngeneically transplanted islets to three different implantation sites of diabetic and nondiabetic rats, then 9–12 weeks later we measured the blood perfusion and compared the tissue partial pressure of oxygen (PO₂) levels of these transplanted islets to endogenous islets. Modified Clark microelectrodes (outer tip diameter 2–6 µm) were used for the oxygen tension measurements, and islet transplant blood perfusion was recorded by laser-Doppler flowmetry (probe diameter 0.45 mm). The islet graft blood perfusion was similar in all islet grafts, irrespective of the implantation site. In comparison, the three implantation organs (the kidney cortex, liver, and spleen) differed markedly in their blood perfusion. There were no differences in islet graft blood perfusion between diabetic and nondiabetic recipients. Within native pancreatic islets, the mean PO₂ was 40 mmHg; however, all transplanted islets had a mean PO₂ of 5 mmHg. The oxygen tension of the grafts did not differ among the implantation sites. In diabetic recipients, an even lower PO₂ level was recorded in the islet transplants. We conclude that the choice of implantation site seems less important than intrinsic properties of the transplanted islets with regard to the degree of revascularization and concomitant blood perfusion. Furthermore, the mean PO₂ level in islets implanted to the kidney, liver, and spleen was markedly decreased at all three implantation sites when compared with native islets, especially in diabetic recipients. These results are suggestive of an insufficient oxygenization of revascularized transplanted islets, irrespective of the implantation site.

CiteULike

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				M. Brissova and A. C. Powers Revascularization of Transplanted Islets: Can It Be Improved? Diabetes, September 1, 2008; 57(9): 2269 - 2271. [Full Text] [PDF]

				R. Miller, V. Cirulli, G. R. Diaferia, S. Ninniri, G. Hardiman, B. E. Torbett, R. Benezra, and L. Crisa Switching-On Survival and Repair Response Programs in Islet Transplants by Bone Marrow-Derived Vasculogenic Cells Diabetes, September 1, 2008; 57(9): 2402 - 2412. [Abstract] [Full Text] [PDF]

				J. Olerud, M. Johansson, J. Lawler, N. Welsh, and P.-O. Carlsson Improved Vascular Engraftment and Graft Function After Inhibition of the Angiostatic Factor Thrombospondin-1 in Mouse Pancreatic Islets Diabetes, July 1, 2008; 57(7): 1870 - 1877. [Abstract] [Full Text] [PDF]

				D. Su, N. Zhang, J. He, S. Qu, S. Slusher, R. Bottino, S. Bertera, J. Bromberg, and H. H. Dong Angiopoietin-1 Production in Islets Improves Islet Engraftment and Protects Islets From Cytokine-Induced Apoptosis Diabetes, September 1, 2007; 56(9): 2274 - 2283. [Abstract] [Full Text] [PDF]

				J. Lau, G. Mattsson, C. Carlsson, D. Nyqvist, M. Kohler, P.-O. Berggren, L. Jansson, and P.-O. Carlsson Implantation Site-Dependent Dysfunction of Transplanted Pancreatic Islets Diabetes, June 1, 2007; 56(6): 1544 - 1550. [Abstract] [Full Text] [PDF]

				J. A. Emamaullee, L. Stanton, C. Schur, and A.M. J. Shapiro Caspase Inhibitor Therapy Enhances Marginal Mass Islet Graft Survival and Preserves Long-Term Function in Islet Transplantation Diabetes, May 1, 2007; 56(5): 1289 - 1298. [Abstract] [Full Text] [PDF]

				R. Lehmann, R. A. Zuellig, P. Kugelmeier, P. B. Baenninger, W. Moritz, A. Perren, P.-A. Clavien, M. Weber, and G. A. Spinas Superiority of Small Islets in Human Islet Transplantation Diabetes, March 1, 2007; 56(3): 594 - 603. [Abstract] [Full Text] [PDF]

				J. Gromada, I. Franklin, and C. B. Wollheim {alpha}-Cells of the Endocrine Pancreas: 35 Years of Research but the Enigma Remains Endocr. Rev., February 1, 2007; 28(1): 84 - 116. [Abstract] [Full Text] [PDF]

				N. Zhang, D. Su, S. Qu, T. Tse, R. Bottino, A.N. Balamurugan, J. Xu, J. S. Bromberg, and H. H. Dong Sirolimus Is Associated With Reduced Islet Engraftment and Impaired {beta}-Cell Function Diabetes, September 1, 2006; 55(9): 2429 - 2436. [Abstract] [Full Text] [PDF]

				J. A. Emamaullee and A.M. J. Shapiro Interventional Strategies to Prevent {beta}-Cell Apoptosis in Islet Transplantation. Diabetes, July 1, 2006; 55(7): 1907 - 1914. [Abstract] [Full Text] [PDF]

				J. A. Emamaullee, R. V. Rajotte, P. Liston, R. G. Korneluk, J. R.T. Lakey, A.M. J. Shapiro, and J. F. Elliott XIAP Overexpression in Human Islets Prevents Early Posttransplant Apoptosis and Reduces the Islet Mass Needed to Treat Diabetes Diabetes, September 1, 2005; 54(9): 2541 - 2548. [Abstract] [Full Text] [PDF]

				D. Nyqvist, M. Kohler, H. Wahlstedt, and P.-O. Berggren Donor Islet Endothelial Cells Participate in Formation of Functional Vessels Within Pancreatic Islet Grafts Diabetes, August 1, 2005; 54(8): 2287 - 2293. [Abstract] [Full Text] [PDF]

				N. R. Barshes, S. Wyllie, and J. A. Goss Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts J. Leukoc. Biol., May 1, 2005; 77(5): 587 - 597. [Abstract] [Full Text] [PDF]

				E. G. Meyron-Holtz, M. C. Ghosh, and T. A. Rouault Mammalian Tissue Oxygen Levels Modulate Iron-Regulatory Protein Activities in Vivo Science, December 17, 2004; 306(5704): 2087 - 2090. [Abstract] [Full Text] [PDF]

				G. Mattsson, L. Jansson, A. Nordin, A. Andersson, and P.-O. Carlsson Evidence of Functional Impairment of Syngeneically Transplanted Mouse Pancreatic Islets Retrieved from the Liver Diabetes, April 1, 2004; 53(4): 948 - 954. [Abstract] [Full Text] [PDF]

				N. Zhang, A. Richter, J. Suriawinata, S. Harbaran, J. Altomonte, L. Cong, H. Zhang, K. Song, M. Meseck, J. Bromberg, et al. Elevated Vascular Endothelial Growth Factor Production in Islets Improves Islet Graft Vascularization Diabetes, April 1, 2004; 53(4): 963 - 970. [Abstract] [Full Text] [PDF]

				A. Omer, V. F. Duvivier-Kali, W. Aschenbach, V. Tchipashvili, L. J. Goodyear, and G. C. Weir Exercise Induces Hypoglycemia in Rats With Islet Transplantation Diabetes, February 1, 2004; 53(2): 360 - 365. [Abstract] [Full Text]

				X. Li, H. Chen, and P. N. Epstein Metallothionein Protects Islets from Hypoxia and Extends Islet Graft Survival by Scavenging Most Kinds of Reactive Oxygen Species J. Biol. Chem., January 2, 2004; 279(1): 765 - 771. [Abstract] [Full Text] [PDF]

				P.-O. Carlsson, A. Nordin, and F. Palm pH is decreased in transplanted rat pancreatic islets Am J Physiol Endocrinol Metab, March 1, 2003; 284(3): E499 - E504. [Abstract] [Full Text] [PDF]

				P.-O. Carlsson, F. Palm, and G. Mattsson Low Revascularization of Experimentally Transplanted Human Pancreatic Islets J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5418 - 5423. [Abstract] [Full Text] [PDF]

				G. Mattsson, L. Jansson, and P.-O. Carlsson Decreased Vascular Density in Mouse Pancreatic Islets After Transplantation Diabetes, May 1, 2002; 51(5): 1362 - 1366. [Abstract] [Full Text] [PDF]